CRDL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	466 007
Average Volume	324 511
Market Cap	180.78M
EPS	$0 ( 2024-05-20 )
Next earnings date	( $-0.0500 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.71
ATR14	$0.00600 (0.23%)

Volume Correlation

Long: 0.24 (neutral)

Short: -0.06 (neutral)

Signal:(47.97) Neutral

Cardiol Therapeutics Inc. Correlation

10 Most Positive Correlations
OZEM	1
JDZG	0.968
COOP	0.934
IBKR	0.928
APXI	0.922
INCR	0.921
QNST	0.918
SLMBP	0.917
EVER	0.917
SHMDW	0.916

10 Most Negative Correlations
GP	-0.916
CVRX	-0.914
DALN	-0.911
LCFY	-0.909
GPRO	-0.906
SYPR	-0.9
OSUR	-0.897
FUV	-0.896
CCRN	-0.892
SABS	-0.892

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cardiol Therapeutics Inc. Correlation - Currency/Commodity

-0.08
( neutral )

-0.06
( neutral )

0.00
( neutral )

0.16
( neutral )

Cardiol Therapeutics Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-248 355 (0.00 %)
EPS:	$-0.440

FY	2023
Revenue:	$0
Gross Profit:	$-248 355 (0.00 %)
EPS:	$-0.440

FY	2022
Revenue:	$0
Gross Profit:	$-219 908 (0.00 %)
EPS:	$-0.490

Financial Reports:

No articles found.

Cardiol Therapeutics Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.